IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM) trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy takes aim at Hard-to-Treat autoimmune diseases
Disease control Recruiting nowThis early-phase trial is testing a new cell therapy called QH103 for people with severe autoimmune diseases like multiple sclerosis and myasthenia gravis that haven't responded to standard treatments. The therapy uses specially engineered immune cells to target and attack the fa…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Experimental cell therapy takes on lupus and muscle disease
Disease control Recruiting nowThis early-stage trial is testing a new treatment called LUCAR-G79D for people with lupus or inflammatory myopathies that haven't responded to standard therapies. The treatment involves giving patients specially engineered immune cells to help control their disease. The study is …
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Phase: PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Immune reset: CAR-T therapy takes on lupus, myositis, and ITP
Disease control Recruiting nowThis early-phase study tests a new cell therapy called BZE2204 in 20 people with lupus, myositis, or immune thrombocytopenia (ITP) that has not responded to standard treatments. The therapy uses a patient's own immune cells, modified to target and calm the overactive immune syste…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHIES(IIM)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:04 UTC